Back

Association of glycated haemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE consortium

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Risk Factors and Prevention ePosters Diabetes and the Heart ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Assistant Professor Christoph Sinning

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

224 More presentations in this session

Presentation thumbnail
High risk characteristics in patients with hypertrophic cardiomiyopathy for predicting cardiovascular events
Doctor B. Keskin Meric (London, GB)
Abstract Slides
Presentation thumbnail
Cardiac biomarkers as prognosticators among SARS-CoV-19 patients in a tertiary hospital in Philippines
Doctor R. Ong (Makati, PH)
Abstract Slides
Presentation thumbnail
Prevalence of atherosclerosis risk factors in Egyptian patients with acute coronary syndromes; final data of the nationwide cross-sectional CardioRisk project
Doctor A. Bendary (Benha, EG)
Abstract Slides
Presentation thumbnail
SF-12 Physical and Mental Health Scales predict cardiovascular events after hospitalization
Mr R. Gascuena (Leganes, ES)
Abstract Slides
Presentation thumbnail
Comparison of traditional versus artificial intelligence based coronary artery disease risk prediction scores in young patients with acute coronary syndrome
Doctor S. Vohra (Lucknow, IN)
Abstract Slides

Access the full session

Session thumbnail
Risk Factors and Prevention ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Hba1c variability is associated with adverse outcomes in heart failure patients with and without diabetes
21 May 2023
thumbnail
Congress Presentation
Population-wide cardiovascular and metabolic screening using point-of-care capillary testing: insights from the UNISCREEN pilot study.
4 April 2025
thumbnail
Congress Presentation
Effect of oral semaglutide on CV outcomes across the vascular disease spectrum, from no vascular disease to polyvascular disease, in high-risk type 2 diabetes
1 September 2025
thumbnail
Congress Presentation
Associations of 1- and 3-methylhistidine with long-term risk of acute myocardial infarction and mortality
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources